P01.08 Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activity

Bibliographic Details
Main Authors:	S Basu, R Ghosh, D Yadav, M Banerjee, R Shrivastava, A Gautam, A Middya, N Mane, N Rawat, D Pryde, A Surya, S Middya, S Debnath, M Padaliya, S Bano
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-03-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items